BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement
Abstract: We investigated B-cell maturation antigen-directed chimeric antigen receptor T-cell (CAR-T) therapy in patients with relapsed or refractory multiple myeloma (MM) and central nervous system (CNS) involvement. Ten patients received either idecabtagene vicleucel (n = 6) or ciltacabtagene auto...
Saved in:
| Main Authors: | Mahmoud R. Gaballa, Omar Castaneda Puglianini, Adam Cohen, Dan Vogl, Alfred Chung, Christopher J. Ferreri, Peter Voorhees, Doris K. Hansen, Krina K. Patel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952924007493 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma
by: Chengwei Jin, et al.
Published: (2025-12-01) -
Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
by: Danai Dima, et al.
Published: (2025-06-01) -
Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma
by: Joshua N. Gustine, et al.
Published: (2025-06-01) -
Resistance Mechanisms to BCMA Targeting Bispecific Antibodies and CAR T-Cell Therapies in Multiple Myeloma
by: Brandon Tedder, et al.
Published: (2025-07-01) -
Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma
by: Jan H. Frenking, et al.
Published: (2025-08-01)